AXA stock gains support as Goldman Sachs lifts price target to 50 euros

AXA stock (ISIN FR0000120620) is trading around 44.70 euros on Euronext Paris as of September 21, 2026, leaving a gap of roughly 12 percent to the median analyst target of 51.00 euros cited in recent summaries. As IT BOLTWISE reported on September 21, 2026, Goldman Sachs has raised its price target for AXA from 48.50 to 50.00 euros while reiterating a Buy rating, adding a fresh catalyst for investors focused on the insurer's medium-term earnings trajectory.

Analysts lift AXA price targets

According to Ideal-Investisseur on September 21, 2026, AXA has benefited from a double target increase: Goldman Sachs lifted its price target from 48.50 to 50.00 euros with a Buy rating, while Autonomous Research raised its target from 45.50 to 50.00 euros with an Outperform recommendation. The same overview notes that the median analyst target for AXA currently stands at 51.00 euros, implying a target price approximately 14.02 percent above the prevailing share price level referenced in that report.

As IT BOLTWISE explains, the Goldman Sachs adjustment reflects updated earnings estimates for AXA for the years 2027 to 2030, which the bank increased by an average of 3.8 percent following an investor day presentation. That uplift in modeled profit over a multi-year horizon underpins the move from a 48.50 euro target to 50.00 euros, while the Buy rating remains unchanged, signaling that Goldman Sachs still sees upside based on the revised long-term assumptions.

Investor day and medium-term earnings trajectory

According to IT BOLTWISE, the revised Goldman Sachs forecasts for 2027 through 2030 were presented as a direct follow-up to an AXA investor day, where management outlined strategic priorities and financial ambitions for the coming years. The analyst cited in the report increased earnings projections by 3.8 percent on average across those years, a change that typically reflects either improved visibility on key profit drivers or higher confidence in margins and capital efficiency over the long term.

For investors, the combination of higher long-run earnings estimates and a stable Buy rating suggests that the core investment case for AXA remains intact while the expected profit trajectory has shifted upward. With the median price target at 51.00 euros and the stock trading around the mid-44 euro range as of September 21, 2026, the implied upside based on the consensus view stays in the low double-digit percent range, even after the recent target increases documented by Ideal-Investisseur.

AXA stock level and technical context

Per data cited by Ideal-Investisseur on September 21, 2026, AXA shares recently returned to their 50-day moving average at 44.31 euros, a level described as a key technical pivot for the stock. A related technical note from the same publisher states that AXA stock has climbed nearly 5 percent over the past week and is targeting a resistance zone around 45.00 euros, underlining that the market has already started to price in some of the improved analyst sentiment.

A separate review from a German-language financial portal, Goldesel, notes that AXA shares were quoted at 44.72 euros on Euronext Paris on September 21, 2026, around 9:50 a.m. local time, representing a daily gain of 0.38 percent and a year-to-date performance of 8.65 percent at that point. In the same coverage, Jefferies is said to have lifted its price target for AXA to 52.50 euros while reaffirming a Buy rating, which, based on the 44.72 euro price snapshot, implies an upside potential of about 17.4 percent.

Closing price and valuation snapshot

On Euronext Paris, AXA stock last changed hands at approximately 44.70 euros on September 21, 2026, with intraday data from around late morning indicating a modest gain versus the prior close and a year-to-date advance in the high single-digit percent range. At this price level and with a median target of 51.00 euros from the analyst community as summarized by Ideal-Investisseur on September 21, 2026, the shares trade at a discount to those targets, leaving potential room for further gains if the insurer delivers on the upgraded earnings path highlighted by Goldman Sachs and other houses.

More news and analyses on AXA stock